Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 199

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Impact of colorectal cancer screening on cancer-specific mortality in Europe: A systematic review

Open access
Gini, Andrea, Jansen, Erik E.L., Zielonke, Nadine, Meester, Reinier G.S., Senore, Carlo, Anttila, Ahti, Segnan, Nereo, Mlakar, Dominika Novak, de Koning, Harry J., Lansdorp-Vogelaar, Iris, Veerus, Piret, Anttila, Ahti, Heinävaara, Sirpa, Sarkeala, Tytti, Csanádi, Marcell, Pitter, Janos, Széles, György, Vokó, Zoltán, Minozzi, Silvia, Segnan, Nereo, Senore, Carlo, van Ballegooijen, Marjolein, Driesprong - de Kok, Inge, Gini, Andrea, Heijnsdijk, Eveline, Jansen, Erik, de Koning, Harry, Lansdorp – Vogelaar, Iris, van Ravesteyn, Nicolien, Zielonke, Nadine, Ivanus, Urska, Jarm, Katja, Mlakar, Dominika Novak, Primic-Žakelj, Maja, McKee, Martin, Priaulx, Jennifer · 2020 · European Journal of Cancer

Abstract

BACKGROUND: Populations differ with respect to their cancer risk and screening preferences, which may influence the performance of colorectal cancer (CRC) screening programs. This review aims to systematically compare the mortality effect of CRC screening across European regions. METHODS: Six databases including Embase, Medline, Web of Science, PubMed publisher, Google Scholar and Cochrane Library were searched for relevant studies published before March 2018. Bibliographic searches were conducted to select studies assessing the effect of various screening tests (guaiac fecal occult blood test [gFOBT]; flexible sigmoidoscopy [FS]; fecal immunochemical test [FIT] and colonoscopy) on CRC mortality in Europe (PROSPERO protocol: CRD42016042433). Abstract reviewing, data extraction and risk of bias assessment were conducted independently by two reviewers. RESULTS: A total of 18 studies were included; of which, 11 were related to gFOBT, 4 to FS, 2 to FIT and 1 to colonoscopy; 8 were randomised clinical trials, and 10, observational studies, and an approximately equal number of studies represented Northern, Western and Southern European regions. Among individuals invited to screening, CRC mortality reductions varied from 8% to 16% for gFOBT and from 21% to 30% for FS. When studies with a high risk of bias were considered, ranges were more extensive. The estimated effectiveness of gFOBT and FS screening appeared similar across different European regions. CONCLUSIONS: CRC mortality impact of inviting individuals with similar adopted screening strategies (gFOBT or FS) may be consistent across several European settings.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ejca.2019.12.014

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 199

Metadata

Authors
Gini, A., Jansen, E. E. L., Zielonke, N., Meester, R. G. S., Senore, C., Anttila, A., Segnan, N., Mlakar, D. N., de Koning, H. J., Lansdorp-Vogelaar, I., Veerus, P., Anttila, A., Heinävaara, S., Sarkeala, T., Csanádi, M., Pitter, J., Széles, G., Vokó, Z., Minozzi, S., Segnan, N., Senore, C., van Ballegooijen, M., Driesprong - de Kok, I., Gini, A., Heijnsdijk, E., Jansen, E., de Koning, H., Lansdorp – Vogelaar, I., van Ravesteyn, N., Zielonke, N., Ivanus, U., Jarm, K., Mlakar, D. N., Primic-Žakelj, M., McKee, M., & Priaulx, J.
Venue
European Journal of Cancer
Publisher
Elsevier BV
Published
2020-03
Volume
127
Pages
224-235
ISSN
0959-8049 (ISSN-L)
OpenAlex
W2999848163
Cited by
199
References
1
FWCI
3.66
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Impact of colorectal cancer screening on cancer-specific mortality in Europe: A systematic review. https://app.cochat.ai/papers/10.1016/j.ejca.2019.12.014
The paper
Gini, A., Jansen, E. E. L., Zielonke, N., Meester, R. G. S., Senore, C., Anttila, A., Segnan, N., Mlakar, D. N., de Koning, H. J., Lansdorp-Vogelaar, I., Veerus, P., Anttila, A., Heinävaara, S., Sarkeala, T., Csanádi, M., Pitter, J., Széles, G., Vokó, Z., Minozzi, S., . . . Priaulx, J. (2020). Impact of colorectal cancer screening on cancer-specific mortality in Europe: A systematic review. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2019.12.014

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.